Cargando…
Effective Cancer Targeting Using an Anti‐tumor Tissue Vascular Endotheliumspecific Monoclonal Antibody (TES‐23)
Immunoconjugate targeting of solid tumors has not been routinely successful because the endothelial cells of blood vessels act as a physical barrier against the transport of macromolecules, such as antibodies. In the present study, we attempted to achieve tumor vascular targeting with an antitumor t...
Autores principales: | Wakai, Yukiko, Matsui, Junji, Koizumi, Keiichi, Tsunoda, Shin‐ichi, Makimoto, Hiroo, Ohizumi, Iwao, Taniguchi, Kenji, Kaiho, Shin‐ichi, Saito, Hiroyuki, Utoguchi, Naoki, Tsutsumi, Yasuo, Nakagawa, Shinsaku, Ohsugi, Yoshiyuki, Mayumi, Tadanori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926302/ https://www.ncbi.nlm.nih.gov/pubmed/11123432 http://dx.doi.org/10.1111/j.1349-7006.2000.tb00920.x |
Ejemplares similares
-
Specific binding of TES-23 antibody to tumour vascular endothelium in mice, rats and human cancer tissue: a novel drug carrier for cancer targeting therapy
por: Tsunoda, S, et al.
Publicado: (1999) -
Isolation and Properties of Tumor‐derived Endothelial Cells from Rat KMT‐17 Fibrosarcoma
por: Utoguchi, Naoki, et al.
Publicado: (1995) -
Intravenous Administration of Polyethylene Glycol‐modified Tumor Necrosis Factor‐α Completely Regressed Solid Tumor in Meth‐A Murine Sarcoma Model
por: Tsutsumi, Yasuo, et al.
Publicado: (1994) -
Effect of tumour cell-conditioned medium on endothelial macromolecular permeability and its correlation with collagen.
por: Utoguchi, N., et al.
Publicado: (1996) -
TEs or not TEs? That is the evolutionary question
por: Vaknin, Keren, et al.
Publicado: (2009)